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The treatment of hydrocephalus has been dramatically
influenced by technical achievements which have been
developed by different companies. One aspect was the
principle phenomenological function of the device with the
aim to lower the likelihood of negative complications like
under - or overdrainage. Beneath these approaches it is
important to observe the performance of the different
devices based on intensive communication with the user.
The manufacturer is not only obligated by law to systema-
tically collect data about the performance of the devices. It
is also important for significant improvement of the
product.
Based on findings followed by systematical analyzes of
revised valves, which have been send back to the manufac-
turer for investigation the proGAV 2.0 has been developed
to address nearly all critical points, which can be recog-
nized during the investigations. Whereas the principle
hydraulic function is nearly unchanged versus the first
generation proGAV the handling, the risk of blockage, the
risk of damaging the valve, the way of adjusting the valve
as well as the verification of the setting have been
improved and the basic technical elements have been
completely reworked. The first clinical experiences sup-
port the intention of the approach as well as the informa-
tion gained by returned valves.
The systematical observation of the performance of medi-
cal devices offers valuable information for improvements.
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